Deutsche Bank Aktiengesellschaft »

Rigel Pharmaceuticals shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2024-06-30 $56k 6.8k 8.22

More positions owned by Deutsche Bank Aktiengesellschaft

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Merck & Co (MRK)
Visa Com Cl A (V)
Johnson & Johnson (JNJ)
UnitedHealth (UNH)
Adobe Systems Incorporated (ADBE)
Qualcomm (QCOM)

View all positions for Deutsche Bank Aktiengesellschaft

Top funds holding Rigel Pharmaceuticals

Armistice Capital
BlackRock
Morgan Stanley
Soleus Capital Management
Vanguard Group
Susquehanna International
Acadian Asset Management
Assenagon Asset Management
Geode Capital Management
State Street Corporation
Stonepine Capital Management
Jacobs Levy Equity Management
Renaissance Technologies
Healthcare Of Ontario Pension Plan Trust Fund
Ing Investment Management

View all funds holding Rigel Pharmaceuticals